Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glaucoma, apoptosis, and neuroprotection.

S J McKinnon1

  • 1Department of Ophthalmology, Johns Hopkins Hospital, Baltimore, MD 21287-9289, USA.

Current Opinion in Ophthalmology
|March 8, 1997
PubMed
Summary

Retinal ganglion cell death, a key factor in glaucoma vision loss, occurs via apoptosis. Understanding this programmed cell death mechanism may reveal new glaucoma treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alpha-fodrin is cleaved by caspase-3 in a chronic ocular hypertensive (COH) rat model of glaucoma.

Brain research bulletin·2004
Same author

Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats.

Investigative ophthalmology & visual science·2000
Same author

Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma.

Investigative ophthalmology & visual science·2000
Same author

Biocompatibility response to modified Baerveldt glaucoma drains.

Journal of biomedical materials research·1998

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Cell Biology

Background:

  • Retinal ganglion cell (RGC) demise is the final pathway for vision loss in glaucoma.
  • RGCs undergo apoptosis, a programmed cell death, in glaucoma and other neurodegenerative conditions.
  • Apoptosis is characterized by specific morphological changes and phagocytosis without inflammation.

Purpose of the Study:

  • To elucidate the cellular and molecular mechanisms of RGC apoptosis in glaucoma.
  • To identify potential therapeutic targets for preventing RGC death and preserving vision.

Main Methods:

  • Review of existing studies on RGC apoptosis in glaucoma models and human glaucoma.
  • Analysis of morphological changes in RGCs using electron microscopy.
  • Investigation of factors implicated in RGC apoptosis, such as neurotrophin withdrawal and excitotoxicity.

Main Results:

  • RGCs in glaucoma undergo apoptosis, a genetically programmed cell death.
  • Morphological hallmarks of apoptosis include chromatin condensation and membrane blebbing.
  • Neurotrophin withdrawal and excitotoxic neurotransmitters are implicated in RGC apoptosis.

Conclusions:

  • Apoptosis is a critical mechanism in glaucomatous RGC death.
  • Further understanding of RGC apoptosis pathways could lead to novel glaucoma treatments.
  • Targeting apoptosis may offer a new strategy for vision preservation in glaucoma.

Related Experiment Videos